Paolo Sandri

532 total citations
14 papers, 385 citations indexed

About

Paolo Sandri is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Paolo Sandri has authored 14 papers receiving a total of 385 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Paolo Sandri's work include Cancer Immunotherapy and Biomarkers (5 papers), Neutropenia and Cancer Infections (3 papers) and Radiomics and Machine Learning in Medical Imaging (1 paper). Paolo Sandri is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), Neutropenia and Cancer Infections (3 papers) and Radiomics and Machine Learning in Medical Imaging (1 paper). Paolo Sandri collaborates with scholars based in Italy and Brazil. Paolo Sandri's co-authors include D. Errante, Mauro Giusto, V. De Pangher, Lara Maria Pasetto, Giuseppe Toffoli, Antonio Russo, Mario D’Andrea, Salvatore Bonura, Paola Biason and S. Pessa and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Oncology.

In The Last Decade

Paolo Sandri

12 papers receiving 376 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paolo Sandri Italy	6	262	183	74	52	42	14	385
Tanja K. Froehlich Switzerland	8	341 1.3×	187 1.0×	76 1.0×	20 0.4×	59 1.4×	11	475
Luis Robles Spain	10	235 0.9×	96 0.5×	46 0.6×	14 0.3×	19 0.5×	32	333
Michael Andria United States	6	283 1.1×	168 0.9×	49 0.7×	7 0.1×	54 1.3×	15	408
F.J. Rodríguez‐Escudero Spain	11	134 0.5×	103 0.6×	39 0.5×	165 3.2×	10 0.2×	47	478
Wittes Re United States	12	215 0.8×	87 0.5×	71 1.0×	27 0.5×	6 0.1×	24	377
Manuela Tamburo De Bella Italy	9	183 0.7×	151 0.8×	60 0.8×	20 0.4×	4 0.1×	16	370
Kevin Imrie Canada	11	140 0.5×	51 0.3×	36 0.5×	24 0.5×	11 0.3×	16	332
Mauro Giusto Italy	5	259 1.0×	189 1.0×	85 1.1×	13 0.3×	42 1.0×	5	360
Shefali Vyas United States	8	127 0.5×	37 0.2×	20 0.3×	57 1.1×	13 0.3×	16	366
J Janssen Netherlands	7	182 0.7×	83 0.5×	35 0.5×	20 0.4×	6 0.1×	14	327

Countries citing papers authored by Paolo Sandri

Since Specialization

Citations

This map shows the geographic impact of Paolo Sandri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paolo Sandri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paolo Sandri more than expected).

Fields of papers citing papers by Paolo Sandri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paolo Sandri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paolo Sandri. The network helps show where Paolo Sandri may publish in the future.

Co-authorship network of co-authors of Paolo Sandri

This figure shows the co-authorship network connecting the top 25 collaborators of Paolo Sandri. A scholar is included among the top collaborators of Paolo Sandri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paolo Sandri. Paolo Sandri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

G, Re, Paolo Doretto, Alessandro Del Conte, et al.. (2018). Cyclophosphamide with or without fluorouracil followed by subcutaneous or intravenous interleukin-2 use in solid tumors: A feasibility off-label experience. Cytokine. 113. 50–60. 2 indexed citations

Cappuzzo, Federico, Angelo Delmonte, Serena Capici, et al.. (2017). P1.06-006 Treatment beyond Progression in Patients with Advanced Squamous NSCLC Participating in the Expanded Access Programme (EAP). Journal of Thoracic Oncology. 12(1). S667–S668. 5 indexed citations

Grossi, Francesco, Lucio Crinò, Annamaria Catino, et al.. (2017). P3.02c-096 Use of Nivolumab in Elderly Patients with Advanced Squamous NSCLC: Results from the Italian Expanded Access Programme (EAP). Journal of Thoracic Oncology. 12(1). S1337–S1338. 2 indexed citations

G, Re, Paolo Doretto, Alessandro Del Conte, et al.. (2017). Cyclophosphamide with (+)/without (-) fluorouracil followed by subcutaneous or intravenous interleukin-2 in solid tumors: An off-label experience.. Journal of Clinical Oncology. 35(15_suppl). e14621–e14621.

Grossi, Francesco, Lucio Crinò, A. Misino, et al.. (2016). Efficacy and safety of nivolumab in elderly patients (pts) with advanced squamous non small cell lung cancer (Sq-NSCLC) participating in the expanded access programme (EAP) in Italy. Annals of Oncology. 27. vi369–vi369. 5 indexed citations

Roever, Leonardo, et al.. (2016). Endovascular Stent Grafting of a Deep Femoral Artery Pseudoaneurysm. SHILAP Revista de lepidopterología. 33. 5–8. 10 indexed citations

Toffoli, Giuseppe, Erika Cecchin, Giuseppe Corona, et al.. (2006). The Role of UGT1A1*28 Polymorphism in the Pharmacodynamics and Pharmacokinetics of Irinotecan in Patients With Metastatic Colorectal Cancer. Journal of Clinical Oncology. 24(19). 3061–3068. 263 indexed citations

Calligaris, Lorenzo, et al.. (1999). [Management of breast cancer in geriatric age; observations on 164 cases].. PubMed. 69(5). 587–94. 1 indexed citations

Mustacchi, Giorgio, et al.. (1998). [Effectiveness of sequential administration of G-CSF and GM-CSF after antineoplastic chemotherapy in patients with advanced tumors: results of a randomized trial].. PubMed. 83(5 Suppl). S13–6. 1 indexed citations

10.

Piga, A., R. Bracci, Paolo Sandri, et al.. (1998). A double blind randomized study of oral clodronate in the treatment of bone metastases from tumors poorly responsive to chemotherapy.. PubMed. 17(2). 213–7. 32 indexed citations

11.

Savastano, Sergio, Diego Miotto, M Chiesura-Corona, et al.. (1992). [Chemoembolization in the therapy of hepatocarcinoma. A 3-year experience].. PubMed. 84(5). 608–12. 1 indexed citations

12.

Ciatto, Stefano, Anna Iossa, Rita Bonardi, et al.. (1990). Male Breast Carcinoma: Review of a Multicenter Series of 150 Cases. Tumori Journal. 76(6). 555–558. 54 indexed citations

13.

Sandri, Paolo, et al.. (1985). Palliative Cryosurgery for Oral Cavity Malignant Melanoma: A Case Report. Tumori Journal. 71(1). 89–90. 3 indexed citations

14.

Mustacchi, Giorgio, et al.. (1984). Telethermography and Axillary Node Status as Predictors of Early Relapse in Breast Cancer: Preliminary Report. Tumori Journal. 70(5). 455–458. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact